BioSpace News Archive

Genetown

Cogent Biosciences Presents New Preclinical Data Highlighting Potential Best-in-Class Potency and Selectivity of ErbB2 and PI3Kα inhibitor programs at the San Antonio Breast Cancer Symposium

Cogent Biosciences, Inc. today presented updated preclinical data from its potent, selective and brain penetrant ErbB2 inhibitor program at the 2023 San Antonio Breast Cancer Symposium (SABCS), taking place December 5-9, 2023 at the Henry B. González Convention Center in San Antonio, Texas.

December 7, 2023
·
7 min read
Biotech Bay

10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain

10x Genomics, Inc., a leader in single cell and spatial biology, announced a collaboration with the NIH Intramural Center for Alzheimer’s and Related Dementias to build a more comprehensive single cell atlas of the human brain to further neuroscience research.

December 7, 2023
·
6 min read
Genetown

Pillar Biosciences to Present at NYBIO | NYSE Life Science Company Showcase on December 14th

Pillar Biosciences is pleased to announce that Randy Pritchard , Chief Executive Officer, and Vincent Ricci , Chief Financial Officer, will be presenting at the NYBIO | NYSE Life Science Company Showcase on December 14th.

December 7, 2023
·
2 min read
Genetown

Kinaset Therapeutics to Present KN-002 Phase 1 Clinical Study Outcomes at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting

Kinaset Therapeutics today announced an upcoming oral presentation at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting being held on February 23-26, 2024.

December 7, 2023
·
1 min read
Biosimilar Market Size to Surpass Around USD 1,26,019.67 Million by 2032

The global biosimilar market size was estimated at USD 25,125.36 million in 2022 and is projected to surpass around USD 1,26,019.67 million by 2032, growing at a CAGR of 17.6% between 2023 and 2032.

December 7, 2023
·
8 min read
Microbix & BioGX Collaborate on real-time PCR Assays & Controls

Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces a collaboration with BioGX, Inc., a global provider of easy molecular diagnostic solutions.

December 7, 2023
·
5 min read
Drug Development

Kymera Therapeutics Announces First Patient Dosed in Phase 2 Atopic Dermatitis Clinical Trial of KT-474 (SAR444656), a First-in-Class, Investigational IRAK4 Degrader, Generating a $15 Million Payment from Sanofi

Kymera Therapeutics, Inc. today announced that the first patient has been dosed in the randomized Phase 2 clinical trial (ADVANTA) evaluating KT-474 (SAR444656) in AD, generating a $15 million milestone payment under its collaboration with Sanofi.

December 7, 2023
·
7 min read
Business

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations

TScan Therapeutics, Inc. today announced the appointment of R. Keith Woods to its Board of Directors. Mr. Woods has over 30 years of life science experience, with expertise in commercialization, sales, global operations, supply chain and business strategy.

December 7, 2023
·
6 min read
Pharm Country

Tilde Sciences acquires Daraprim® and Vecamyl® from Vyera Pharmaceuticals

Tilde Sciences, a specialty pharmaceutical company, announced today that it has acquired two medicines, Daraprim® and Vecamyl® from Vyera Pharmaceuticals.

December 7, 2023
·
1 min read
BioMidwest

Sarah Cannon Research Institute to Present Latest Research Insights at the 2023 ASH Annual Meeting & Exposition

Sarah Cannon Research Institute announced that more than 80 abstracts and presentations have been selected for inclusion at the 65th American Society of Hematology Annual Meeting & Exposition.

December 7, 2023
·
8 min read